|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
FY2021
12 months to Mar 31, 2021
|
|
|---|---|---|---|
| Operating activities | |||
| Net loss for the year | |||
| Depreciation | |||
| Stock based compensation | |||
| Government grant expense recoveries (Note 7) | |||
| Unrealized foreign exchange | |||
| Accrued interest | |||
| Other receivables and deposits | |||
| Accounts payable and accrued liabilities | |||
| Net cash flows from (used in) operating activities | |||
| Investing activities | |||
| Acquisition of marketable securities | |||
| Disposition of marketable securities | |||
| Net cash flows from (used in) investing activities | |||
| Financing activities | |||
| Repayment of lease liabilities | |||
| Warrant and option exercises (Notes 10 and 11) | |||
| Net cash flows from (used in) financing activities | |||
| Effect of foreign exchange on cash | |||
| Net increase (decrease) in cash | |||
| Cash, beginning of year | |||
| Cash, end of year | |||
| Other non-cash transactions | |||
| Broker warrants issued | |||
| Warrants issued | |||
| Share issuance costs accrued through accounts payable and accrued liabilities |
Loading...
